Denali Therapeutics Stock News

Cuevana2ios January 11, 2022

The shares were sold at an average price of $44.92, for a total transaction of $823,518.36. Tweet on twitter share on facebook google+ pinterest.

Dnli Stock Price And Chart Nasdaqdnli Tradingview

Dakota financial news | november 14, 2021.

Denali therapeutics stock news. Denali therapeutics reports third quarter 2021 financial results and business highlight. Their forecasts range from $70.00 to $111.00. On average, they expect denali therapeutics' stock price to reach $93.29 in the next year.

A form 4 filing from the u.s. The decline came after the company. Press release reported 23 hours ago that denali therapeutics announces positive interim data from phase 1/2 study with etv:ids (dnl310) in patients with the lysosomal.

Ryan watts, president and ceo at denali therapeutics (nasdaq:dnli), made a large insider sell on september 1, according to a new sec filing. 8 brokerages have issued 1 year target prices for denali therapeutics' shares. President and ceo of denali therapeutics sold $1.00 million in stock.

The stock had previously closed at $54.10, but opened at $50.71. Shares of denali therapeutics inc. Shares of denali therapeutics ( nasdaq:dnli) had sunk 11.2% as of 12:02 p.m.

Securities and exchange commission on wednesday showed. This suggests a possible upside of 98.0% from the stock's current price. (nasdaq:dnli) gapped down prior to trading on tuesday after an insider sold shares in the company.

(nasdaq:dnli) gapped down prior to trading on tuesday after an insider sold shares in the company. Denali therapeutics (nasdaq:dnli) shares gap down following insider selling. Denali therapeutics shares last traded at $52.87, with a volume of 2,179 shares traded.

Home news why denali therapeutics stock is sinking today. With a price/earnings ratio of 223.47, denali therapeutics inc p/e ratio is greater than that of about 96.7% of stocks in our set with positive earnings. Dnli) had sunk 11.2% as of 12:02 p.m.

The stock had previously closed at $54.10, but opened at $50.71. Dnli | complete denali therapeutics inc. Denali therapeutics unveiled promising test results in hunter syndrome, but dnli stock tanked on monday as investors questioned the viability of the biotech's broader platform.

Denali therapeutics started at outperform with $85 stock price target at oppenheimer. Oppenheimer has initiated shares of denali therapeutics with a buy rating saying the company is an underappreciated emerging leader in neurodegeneration and cns disorders. Shares of denali therapeutics inc.

Of note is the ratio of denali therapeutics inc's sales and general administrative expense to its total operating expenses; Over 50 finance july 26, 2021 comments off. Get the latest stock news for nasdaq companies, press releases, financial disclosures and multimedia content, for day traders, investment community, individual investors and the general public.

(dnli) came out with a quarterly loss of $0.69 per share versus the zacks consensus estimate of a loss of $0.51. Data is currently not available. Get the latest denali therapeutics stock price and detailed information including dnli news, historical charts and realtime prices.

Reports earnings results for the third quarter and nine months. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Why denali therapeutics stock is sinking today.

Earnings flash (dnli) denali therapeutics reports q3 revenue $5.3m. In other denali therapeutics news, ceo ryan j. Shares of denali therapeutics (nasdaq:

Denali therapeutics (nasdaq:dnli) shareholder returns have been stellar, earning 206% in 3 years. Watts sold 18,333 shares of the stock in a transaction that occurred on wednesday, december 1st. 06:01am, thursday, 11'th nov 2021 dakota financial news.

The decline came after the company presented interim results on sunday from a phase 1/2 study evaluating.

Denali Dnli Stock Up Despite Wider-than-expected Q3 Loss Nasdaq